MICHELLE SANFORD: Open Payments
NPI 1487076873 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,251 in 109 payments from 34 companies in 2025. Trend: 2023 $1,744 · 2024 $1,606 · 2025 $2,251
Food & beverage: $2,251
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $229 |
| AstraZeneca Pharmaceuticals LP | 11 | $207 |
| Merck Sharp & Dohme LLC | 9 | $203 |
| Celgene Corporation | 7 | $188 |
| Daiichi Sankyo Inc. | 7 | $169 |
| E.R. Squibb & Sons, L.L.C. | 6 | $116 |
| Incyte Corporation | 5 | $108 |
| PFIZER INC. | 6 | $100 |
| Janssen Biotech, Inc. | 5 | $88 |
| Genentech USA, Inc. | 4 | $80 |
Products named: KEYTRUDA, Enhertu, OPDIVO, REBLOZYL, IMFINZI, PLUVICTO, KISQALI, JAKAFI.
Industry payments across AL — which companies pay providers there.
